What is Envoy Medical's G&A?

Envoy Medical (COCH) reported G&A of $1.88M in Q1 2026.

How has Envoy Medical's G&A changed year-over-year?

Envoy Medical's G&A increased by 3.2% year-over-year, from $1.82M to $1.88M.

What is the long-term trend for Envoy Medical's G&A?

Over 2 years (2023 to 2025), Envoy Medical's G&A has grown at a 4.5% compound annual growth rate (CAGR), from $7.26M to $7.93M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Envoy Medical COCH G&A

G&A at other companies

Travel + LeisureTNL

$121M-0.8%

Main Street CapitalMAIN

$5.4M+6.1%

HES

Hess MidstreamHESM

$7.9M+5.3%

Oaktree Specialty LendingOCSL

$1.18M+25.4%

Dianthus TherapeuticsDNTH

$12.47M+69.9%

IPG PhotonicsIPGP

$36.09M+10.0%

Other financials

Income statement

See full

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

See full

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

See full

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

See full

Market cap$61M+83.5%

P/S260.7×+111×

Profitability

See full

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

See full

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Envoy Medical's G&A?: Envoy Medical (COCH) reported G&A of $1.88M in Q1 2026.
How has Envoy Medical's G&A changed year-over-year?: Envoy Medical's G&A increased by 3.2% year-over-year, from $1.82M to $1.88M.
What is the long-term trend for Envoy Medical's G&A?: Over 2 years (2023 to 2025), Envoy Medical's G&A has grown at a 4.5% compound annual growth rate (CAGR), from $7.26M to $7.93M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.